Toggle menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Diagnostic and Statistical Manual: Difference between revisions

From ProleWiki, the proletarian encyclopedia
More languages
(Created page with "The '''Diagnostic and Statistical Manual of Mental Disorders''' (abbreviation: '''DSM''') is a publication of works that classify psychiatric disorders. The '''DSM''' is created and published by the American Psychiatric Association. ==Criticisms== There are a number of different criticisms that have been leveled against the DSM and its usefulness as a diagnostic manual. ===Lack of Objective Analysis=== The DSM does not require the use of objective analysis. ===Fin...")
 
Line 8: Line 8:


===Financial conflicts of interest===
===Financial conflicts of interest===
The DSM had received funding from pharmaceutical companies.
A large portion of the designing staff of the DSM-IV had received funding, in some method, from pharmaceutical companies.<ref name='10.1159/000091772'>{{Citation|doi=10.1159/000091772|author=Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L.|year=2006|title=Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry|journal=Psychotherapy and Psychosomatics|volume=75(3f)|page=154–160}}</ref>
 
[[Category:Psychiatry]]
[[Category:Psychiatry]]

Revision as of 21:55, 2 November 2022

The Diagnostic and Statistical Manual of Mental Disorders (abbreviation: DSM) is a publication of works that classify psychiatric disorders. The DSM is created and published by the American Psychiatric Association.

Criticisms

There are a number of different criticisms that have been leveled against the DSM and its usefulness as a diagnostic manual.

Lack of Objective Analysis

The DSM does not require the use of objective analysis.

Financial conflicts of interest

A large portion of the designing staff of the DSM-IV had received funding, in some method, from pharmaceutical companies.[1]

  1. Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L. (2006). Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry. Psychotherapy and Psychosomatics, vol.75(3f) (pp. 154–160). doi: 10.1159/000091772 [HUB]